162 related articles for article (PubMed ID: 37158349)
1. Diagnosis of Mycosis Fungoides after Dupilumab Treatment for Atopic Dermatitis.
O'Neill L; Duffy RF; Manders SM
Skinmed; 2023; 21(2):105-106. PubMed ID: 37158349
[TBL] [Abstract][Full Text] [Related]
2. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
Ayasse M; Nelson K; Glass F; Silverberg JI
Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
[No Abstract] [Full Text] [Related]
3. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
Joshi TP; Duvic M
J Am Acad Dermatol; 2023 Jun; 88(6):e305-e306. PubMed ID: 36858155
[No Abstract] [Full Text] [Related]
4. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story.
Guitart J
JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433
[No Abstract] [Full Text] [Related]
5. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis.
Chiba T; Nagai T; Osada SI; Manabe M
Acta Derm Venereol; 2019 Jul; 99(9):818-819. PubMed ID: 31045233
[No Abstract] [Full Text] [Related]
6. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.
Jfri A; Smith JS; Larocca C
J Am Acad Dermatol; 2023 May; 88(5):1164-1166. PubMed ID: 36481378
[No Abstract] [Full Text] [Related]
7. Dupilumab-associated mycosis fungoides: a cross-sectional study.
Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
[TBL] [Abstract][Full Text] [Related]
8. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
[No Abstract] [Full Text] [Related]
9. Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.
Sokumbi O; Shamim H; Davis MDP; Wetter DA; Newman CC; Comfere N
Am J Dermatopathol; 2021 Oct; 43(10):714-720. PubMed ID: 34132660
[TBL] [Abstract][Full Text] [Related]
10. Treatment of refractory conjunctivitis associated to dupilumab with topical pimecrolimus applied to the eyelid skin.
Sernicola A; Gattazzo I; Di Staso F; Giordano D; Capalbo A; Persechino F; Scuderi G; Persechino S
Dermatol Ther; 2019 Nov; 32(6):e13134. PubMed ID: 31639238
[TBL] [Abstract][Full Text] [Related]
11. Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis.
Netravali IA; Sockler PG; Heimall J; Treat JR
Pediatr Dermatol; 2024; 41(2):275-278. PubMed ID: 37680146
[TBL] [Abstract][Full Text] [Related]
12. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
[TBL] [Abstract][Full Text] [Related]
13. [Folliculotropic mycosis fungoides].
Baratli J; Balakirski G; Megahed M
Hautarzt; 2014 Dec; 65(12):1011-3. PubMed ID: 25355498
[TBL] [Abstract][Full Text] [Related]
14. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
[TBL] [Abstract][Full Text] [Related]
15. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
Paller AS; Siegfried EC; Thaçi D; Wollenberg A; Cork MJ; Arkwright PD; Gooderham M; Beck LA; Boguniewicz M; Sher L; Weisman J; O'Malley JT; Patel N; Hardin M; Graham NMH; Ruddy M; Sun X; Davis JD; Kamal MA; Khokhar FA; Weinreich DM; Yancopoulos GD; Beazley B; Bansal A; Shumel B
J Am Acad Dermatol; 2020 Nov; 83(5):1282-1293. PubMed ID: 32574587
[TBL] [Abstract][Full Text] [Related]
18. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
Liberman P; Shifera AS; Berkenstock M
Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
[TBL] [Abstract][Full Text] [Related]
19. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M
Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.
Matsutani M; Imai Y; Inoue Y; Nakatani-Kusakabe M; Natsuaki M; Yamanishi K; Kanazawa N
J Dermatol; 2021 Oct; 48(10):1564-1568. PubMed ID: 34155694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]